← Back to directory

Paul M. O’Byrne

Researcher Next ID · RN-032964

Researcher · Medicine

Institute for Respiratory Health

Nedlands, Canada

Accepting doctoral researchersFunding unknown
Works count
877
Citation count
56,123
H-index
113
i10-index
470

Research interests

Medicine
Asthma and respiratory diseases
Respiratory and Cough-Related Research
Allergic Rhinitis and Sensitization
Inhalation and Respiratory Drug Delivery
Chronic Obstructive Pulmonary Disease (COPD) Research

Publications

  • Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1715274

  • As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma

    New England Journal of Medicine · 2018 · 10.1056/nejmoa1715275

  • A summary of the new GINA strategy: a roadmap to asthma control

    European Respiratory Journal · 2015 · 10.1183/13993003.00853-2015

  • Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial

    The Lancet Respiratory Medicine · 2015 · https://doi.org/10.1016/s2213-2600(15)00197-6

  • Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia

    Journal of Allergy and Clinical Immunology · 2015 · 10.1016/j.jaci.2015.05.037

  • Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses

    New England Journal of Medicine · 2014 · 10.1056/nejmoa1402895

  • Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

    Journal of Allergy and Clinical Immunology · 2010 · https://doi.org/10.1016/j.jaci.2010.07.019

  • Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis

    American Journal of Respiratory and Critical Care Medicine · 2009 · 10.1164/rccm.200810-1534oc

  • Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

    New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0805435

  • An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

    American Journal of Respiratory and Critical Care Medicine · 2009 · https://doi.org/10.1164/rccm.200801-060st

  • Severe Exacerbations and Decline in Lung Function in Asthma

    American Journal of Respiratory and Critical Care Medicine · 2008 · 10.1164/rccm.200807-1126oc

  • A new perspective on concepts of asthma severity and control

    European Respiratory Journal · 2008 · https://doi.org/10.1183/09031936.00155307

  • Global strategy for asthma management and prevention: GINA executive summary

    European Respiratory Journal · 2007 · https://doi.org/10.1183/09031936.00138707

  • Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Asthma

    American Journal of Respiratory and Critical Care Medicine · 2004 · 10.1164/rccm.200407-884oc

  • Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

    The Lancet · 2003 · 10.1016/s0140-6736(03)12891-7

  • Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma

    American Journal of Respiratory and Critical Care Medicine · 2001 · 10.1164/ajrccm.164.8.2104102

  • Development and validation of a questionnaire to measure asthma control

    European Respiratory Journal · 1999 · https://doi.org/10.1034/j.1399-3003.1999.14d29.x

  • Treatment of Asthma with Drugs Modifying the Leukotriene Pathway

    New England Journal of Medicine · 1999 · 10.1056/nejm199901213400306

  • Managing Cough as a Defense Mechanism and as a Symptom

    CHEST Journal · 1998 · 10.1378/chest.114.2_supplement.133s

  • Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma

    New England Journal of Medicine · 1997 · https://doi.org/10.1056/nejm199711133372001

  • A comparison of the efficacy and safety of inhaled corticosteroids in asthma

    Allergy · 1997 · https://doi.org/10.1111/j.1398-9995.1997.tb05047.x

  • Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults

    European Respiratory Journal · 1993 · 10.1183/09041950.053s1693

  • Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor Antagonist

    New England Journal of Medicine · 1990 · 10.1056/nejm199012203232504

  • Effect of Long-term Treatment with an Inhaled Corticosteroid (Budesonide) on Airway Hyperresponsiveness and Clinical Asthma in Nonsteroid-dependent Asthmatics

    American Review of Respiratory Disease · 1990 · 10.1164/ajrccm/142.4.832

  • Late Asthmatic Responses

    American Review of Respiratory Disease · 1987 · 10.1164/ajrccm/136.3.740

  • Bronchoalveolar Cell Profiles of Asthmatic and Nonasthmatic Subjects

    American Review of Respiratory Disease · 1987 · 10.1164/ajrccm/136.2.379

  • Importance of airway inflammation for hyperresponsiveness induced by ozone.

    PubMed · 1983 · https://doi.org/10.1164/arrd.1983.127.6.686

  • Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance

    Journal of Allergy and Clinical Immunology · 1981 · 10.1016/0091-6749(81)90132-9

Current projects

    No projects listed.